You have 9 free searches left this month | for more free features.

stage III adult diffuse small cleaved cell lymphoma

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

Completed
  • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
  • Gdansk, Poland
    Medical University of Gdansk
Jan 8, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +110 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 6, 2019

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Composite Lymphoma, Grade 3b Follicular Lymphoma, Stage I DLBCL Trial in Seattle (drug, other, biological)

Completed
  • Composite Lymphoma
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 22, 2020

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

Terminated
  • Non-Hodgkin's B-cell Lymphoma
  • +5 more
  • MT-3724 Phase 1
  • MT-3724 Phase 2
  • Tucson, Arizona
  • +40 more
Jul 18, 2022

Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • rituximab
  • +10 more
  • Portland, Oregon
  • +14 more
Jan 29, 2021

Non Small Cell Lung Cancer Trial in Italy (Alectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Meldola, Forlì-Cesena, Italy
  • +19 more
Aug 16, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Hematological Malignancies Trial in United States (KPG-818)

Recruiting
  • Hematological Malignancies
  • Sacramento, California
  • +9 more
Jul 4, 2022

DLBCL Trial in Worldwide (Polatuzumab Vedotin, Rituximab, Gemcitabine)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +3 more
  • Hollywood, Florida
  • +89 more
Jan 31, 2023

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Hematologic Cancer Trial in Israel, United States (ABBV-101)

Not yet recruiting
  • Hematologic Cancer
  • Lone Tree, Colorado
  • +7 more
Feb 22, 2023

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Lymphoma, Large B-Cell, Diffuse, Stage III Follicular Lymphoma Trial in Shanghai (Metformin, Placebos)

Unknown status
  • Lymphoma, Large B-Cell, Diffuse
  • Stage III Follicular Lymphoma
  • Shanghai, China
    Ruijin Hospital
Mar 9, 2020

Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood

Active, not recruiting
  • Adult T Acute Lymphoblastic Leukemia
  • +7 more
  • Birmingham, Alabama
  • +211 more
Jan 26, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Non-Hodgkin Lymphoma Trial in Worldwide (Tisagenlecleucel after optional bridging and lymphodepleting chemo, Platinum-based

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
  • Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
  • La Jolla, California
  • +66 more
Jan 6, 2023

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Duarte, California
  • +2 more
Nov 10, 2022

NSCLC Trial in Tianjin (Ensartinib, Placebo)

Recruiting
  • Non-small Cell Lung Cancer
  • Tianjin, China
    TianJin Medical University Cancer Institute & Hospital
Jul 13, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2023

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,

Completed
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +15 more
  • dendritic cell vaccine therapy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 13, 2020

Anemia, Leukemia, Lymphoma Trial in Los Angeles (darbepoetin alfa, epoetin alfa)

Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • epoetin alfa
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

EBV-induced Lymphomas, EBV-associated Malignancies, Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent

Completed
  • EBV-induced Lymphomas
  • +2 more
  • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2020

Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )

Completed
  • Cervical Cancer
  • +8 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020